The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review

INTRODUCTION: Rheumatic diseases are autoimmune, inflammatory diseases often associated with cardiovascular (CV) disease, a major cause of mortality in these patients. In recent years, treatment with biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs), either as monothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmohamed, Michael, Choy, Ernest, Lula, Sadiq, Kola, Blerina, DeMasi, Ryan, Accossato, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938314/
https://www.ncbi.nlm.nih.gov/pubmed/29318514
http://dx.doi.org/10.1007/s40264-017-0628-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938314/
https://www.ncbi.nlm.nih.gov/pubmed/29318514
http://dx.doi.org/10.1007/s40264-017-0628-9

Ejemplares similares